Heartwood Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$292K Buy
1,116
+68
+6% +$17.4K 0.02% 186
2026
Q2
$264K Hold
1,048
– – 0.02% 206
2026
Q1
$228K Sell
1,048
-156
-13% -$34.6K 0.02% 211
2025
Q4
$275K Sell
1,204
-19
-2% -$4.33K 0.03% 168
2025
Q3
$283K Buy
1,223
+20
+2% +$4.07K 0.03% 165
2025
Q2
$223K Hold
1,203
– – 0.02% 179
2025
Q1
$252K Hold
1,203
– – 0.03% 157
2024
Q4
$214K Hold
1,203
– – 0.02% 165
2024
Q3
$238K Hold
1,203
– – 0.03% 158
2024
Q2
$206K Hold
1,203
– – 0.02% 168
2024
Q1
$219K Sell
1,203
-118
-9% -$20.3K 0.03% 150
2023
Q4
$205K Buy
+1,321
New +$193K 0.03% 144
2023
Q2
– Sell
-1,507
Closed -$240K – 141
2023
Q1
$240K Buy
+1,507
New +$230K 0.04% 113
2022
Q2
– Sell
-1,384
Closed -$224K – 116
2022
Q1
$224K Buy
+1,384
New +$201K 0.03% 111

Other funds holding ABBV

Heartwood Wealth Advisors's ABBV Position: Q3 2026 in Review

Heartwood Wealth Advisors increased its AbbVie (ABBV) stake by 6.5% in Q3 2026, buying an estimated $17.4K and bringing the position to 1,116 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #186.

Heartwood Wealth Advisors first reported a position in ABBV in Q1 2022 and has held it in 14 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Heartwood Wealth Advisors held 1,116 shares of AbbVie worth $292K as of Q3 2026.
  • Heartwood Wealth Advisors bought 68 AbbVie shares in Q3 2026, an estimated $17.4K.
  • AbbVie made up 0.02% of Heartwood Wealth Advisors's portfolio in Q3 2026, its #186 holding.
  • Heartwood Wealth Advisors first reported a position in AbbVie in Q1 2022 and has held it in 14 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Heartwood Wealth Advisors's 13F filing for Q3 2026, filed 5 Oct 2026.